Furthermore, FGF23 and phosphate have emerged as pertinent factors in cancer pathophysiology, with FGF23 being particularly relevant for cancer types that predominantly affect bone health (e.g., multiple myeloma) or exhibit bone metastases [15]. This evidence concerns the gene FGF23 and plasma cell myeloma.